
|Videos|March 23, 2022
Questions Regarding the Link Between Vitamin D Levels and COVID-19
Author(s)Saro Arakelians, PharmD
Study suggests a link between vitamin D deficiency and COVID-19 severity and mortality.
Advertisement
The study was based on the findings from the initial waves of Israel’s COVID-19 outbreak prior to vaccines becoming widely available. The researchers found that patients with vitamin D deficiency were more likely to develop a severe or critical case of COVID-19 compared with those who have sufficient levels of vitamin D in their blood.
The study showed that individuals with vitamin D deficiency were 14 times more likely to develop a severe or critical case of COVID-19. Further, mortality rates for patients with insufficient vitamin D levels was found to be 25.6% versus 2.3% among individuals with adequate vitamin D levels.
Advertisement
Related to this article

Two Kidney Week 2026 abstracts show a dose-response link between cardiovascular-kidney-metabolic syndrome (CKM) stage and chronic kidney disease (CKD), while primary care clinicians cite evidence and workflow barriers.

In more than 262,000 UK Biobank participants, a 5-marker cardiometabolic score was linked to graded risk at each step toward CKM multimorbidity.

Two IDWeek 2026 studies link influenza vaccination to fewer ICU admissions in older adults and fewer emergency visits in children.

The approval offers a once-weekly basal insulin treatment option for patients, reducing the frequency of injections.

Early data suggest the 7 PCV20-added serotypes are causing a smaller share of invasive pneumococcal disease in children younger than 2 years.

In pooled CORALreef data, patients with eGFR below 60 had a 65.9% placebo-adjusted LDL-C reduction at week 24, with safety comparable to placebo.

Pharmacy Times will feature experts on kidney function assessment, IgG4-related disease, emerging CKD therapies, and gaps in cardiorenal care.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Flu Vaccination Linked to Fewer Severe Outcomes in Older Adults, Fewer ED Visits in Children
2
Combined Cardiometabolic Biomarker Burden Tracks CKM Progression
3
FDA Approves Awiqli, Once-Weekly Insulin, for Children Aged 10 Years and Older With T2D
4
Kidney Week 2026: What to Know for Nephrology's Biggest Meeting
5

